Parchem Lab

Ronald j. parchem., ph.d.

Ron Parchem received a B.S. from University of Illinois at Urbana-Champaign, and his Ph.D. from University of California, Berkeley. He did his post-doctoral studies at University of California, San Francisco until he began at Baylor College of Medicine in 2015.


Young-sun oh, ph.d.

Dr. Young Sun Oh got her M.S. and PhD. in Biology from University of Sungkyunkwan and researched in Molecular Medicine and Biopharmaceutical Science program at Seoul National University. She is currently a Postdoctoral fellow in the Parchem lab. She is interested in neural crest development and has skills in molecular biology, cell biology,  and animal biology. Her current projects include phenotyping the miR-302 KO mouse. and the role of miR-302 during neural crest induction.


Tessa clark

Tessa manages the Parchem lab and maintains all ordering and equipment. Tessa has thirteen years of experience investigating metabolic diseases and oncologic indications in both biotech and academia. She has expertise in mouse disease modeling, drug induction models, and patient derived xenograft models, in vitro and ex vivo cell based assay development, qRT-PCR, mouse surgery, and pharmacologic applications.

portrait small.jpg

Shahab younesi

Shahab Younesi got his B.S. in biotechnology from California State University Northridge and a M.S. through the CIRM-BRIDGES program at California State University Northridge. He then worked at Cedars-Sinai Medical Center in the Regenerative Medicine Institute until he began his Ph.D. in neuroscience as a graduate student in the Parchem lab. He is interested in studying the transition from pluripotency to a committed neural cell-fate by studying the specification of the neuroepithelium.


Angelina "gina" bortoletto

Gina is currently in her third year of the Baylor M.D./ Ph.D. program and recently joined the Parchem lab as a first-year graduate student. After graduating from New Mexico State University with a degree in biochemistry, she worked as a research technician at MD Anderson for 2 years before beginning her training at Baylor College of Medicine. She is interested in studying the cancer stem cell population.


Rachel keuls